EN

endo-avoid-sympathomimetic-cvd

A clinical support tool for identifying safe, non-sympathomimetic pharmacological weight-loss options for high-risk cardiac patients.

Install

mkdir -p .claude/skills/endo-avoid-sympathomimetic-cvd && curl -L -o skill.zip "https://agentskills.codes/api/skills/download/16927" && unzip -o skill.zip -d .claude/skills/endo-avoid-sympathomimetic-cvd && rm skill.zip

Installs to .claude/skills/endo-avoid-sympathomimetic-cvd

Activation

This is the description your AI agent reads to decide when to run this skill — the better it matches your request, the more reliably it fires.

Recommends using non‑sympathomimetic agents (lorcaserin, orlistat) for pharmacological weight loss in patients with cardiovascular disease. Triggers include clinician questions such as “What weight‑loss medication is safest for this patient with coronary artery disease?” or “Should I avoid phentermine in a patient with prior stroke seeking obesity treatment?”.
362 charsno explicit “when” triggerlonger than Claude Code's old 250-char listing cap (fine on current versions)
Advanced

Key capabilities

  • Gather patient information on cardiovascular disease (CVD) presence
  • Assess BMI and review current medications for sympathomimetic contraindications
  • Determine if the patient is seeking pharmacological weight loss with CVD
  • Choose lorcaserin if no concomitant serotonergic drugs or psychiatric contraindications
  • Select orlistat if no chronic malabsorption, cholestasis, pregnancy, or breastfeeding
  • Prescribe lorcaserin or orlistat as an adjunct to lifestyle modification

How it works

The skill gathers patient information to determine CVD presence and other contraindications. It then rules in/out the need for specific non-sympathomimetic agents and classifies the appropriate medication (lorcaserin or orlistat) based on patient conditions.

Inputs & outputs

You give it
Patient history including CVD status, BMI, current medications, and weight-loss goals
You get back
A recommendation for lorcaserin or orlistat for pharmacological weight loss, or a determination that standard weight-loss medication selection applies

When to use endo-avoid-sympathomimetic-cvd

  • Choose weight-loss meds for CAD patients
  • Assess sympathomimetic contraindications
  • Document cardiac safety for prescriptions

About this skill

Avoid sympathomimetics in CVD for weight loss

STEP 1 — Gather Information

Determine presence of cardiovascular disease (CAD, prior stroke, heart failure, PAD) or uncontrolled hypertension/history of heart disease; assess BMI ≥27 kg/m² with comorbidity or ≥30 kg/m²; review current medications for sympathomimetic contraindications (MAOIs, SSRIs) and obtain baseline weight, BP, heart rate.

STEP 2 — Rule In / Rule Out

If patient has CVD (or uncontrolled hypertension/history of heart disease) and is seeking pharmacological weight loss → proceed; otherwise, standard weight‑loss medication selection applies.

STEP 3 — Classify or Stratify

Choose lorcaserin if no concomitant serotonergic drugs (SSRI/SNRI/MAOI/triptan) and no psychiatric contraindications; otherwise select orlistat if no chronic malabsorption, cholestasis, pregnancy, or breastfeeding.

STEP 4 — Decide

Prescribe lorcaserin 10 mg BID or orlistat 120 mg TID as adjunct to lifestyle modification; document avoidance of phentermine/diethylpropion and arrange monthly follow‑up for efficacy and safety.

Clinical Guardrails / Mimics / Pitfalls

Do not prescribe sympathomimetics (phentermine, diethylpropion) in CVD; avoid lorcaserin with serotonergic agents due to serotonin syndrome risk; avoid orlistat in patients with chronic malabsorption, cholestasis, pregnancy, or breastfeeding; monitor BP and heart rate; ensure concurrent diet, exercise, and behavioral therapy.

Concrete Clinical Example

A 60‑year‑old woman with prior ischemic stroke (BMI 31) asks for weight‑loss aid; she takes atorvastatin and aspirin, no antidepressants. After confirming CVD and no serotonergic meds, orlistat 120 mg TID is started; phentermine is avoided due to stroke history.

Source: Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2014-3415

When not to use it

  • When the patient does not have CVD or uncontrolled hypertension/history of heart disease
  • When the patient is not seeking pharmacological weight loss

Limitations

  • The skill recommends using non-sympathomimetic agents.
  • The skill avoids lorcaserin with serotonergic agents due to serotonin syndrome risk.
  • The skill avoids orlistat in patients with chronic malabsorption, cholestasis, pregnancy, or breastfeeding.

How it compares

This skill provides a structured, step-by-step clinical guideline for selecting weight-loss medication for patients with cardiovascular disease, specifically avoiding sympathomimetics, unlike a general medication recommendation system.

Compared to similar skills

endo-avoid-sympathomimetic-cvd side by side with the closest alternatives in the catalog.

SkillInstallsUpdatedSafetyDifficulty
endo-avoid-sympathomimetic-cvd (this skill)01moNo flagsAdvanced
legal-risk-assessment36moNo flagsIntermediate
lex04moReviewAdvanced
neqsim_standard_requirement_extraction01moNo flagsIntermediate

Try saying

Example prompts that trigger this skill in your AI assistant.

You might also like

legal-risk-assessment

anthropics

Assess and classify legal risks using a severity-by-likelihood framework with escalation criteria. Use when evaluating contract risk, assessing deal exposure, classifying issues by severity, or determining whether a matter needs senior counsel or outside legal review.

336

lex

Anhvu1107

ALWAYS use this when the request matches LEX: Centralized ''Truth Engine'' for cross-jurisdictional legal context (US, EU, CA) and contract scaffolding.

00

neqsim_standard_requirement_extraction

equinor

Extract and map engineering requirements from standards or approved standards

00

contract-review

anthropics

Review contracts against your organization's negotiation playbook, flagging deviations and generating redline suggestions. Use when reviewing vendor contracts, customer agreements, or any commercial agreement where you need clause-by-clause analysis against standard positions.

728

literature-review

K-Dense-AI

Conduct comprehensive, systematic literature reviews using multiple academic databases (PubMed, arXiv, bioRxiv, Semantic Scholar, etc.). This skill should be used when conducting systematic literature reviews, meta-analyses, research synthesis, or comprehensive literature searches across biomedical, scientific, and technical domains. Creates professionally formatted markdown documents and PDFs with verified citations in multiple citation styles (APA, Nature, Vancouver, etc.).

5591,298

openalex-database

davila7

Query and analyze scholarly literature using the OpenAlex database. This skill should be used when searching for academic papers, analyzing research trends, finding works by authors or institutions, tracking citations, discovering open access publications, or conducting bibliometric analysis across 240M+ scholarly works. Use for literature searches, research output analysis, citation analysis, and academic database queries.

48202

Search skills

Search the agent skills registry